drugset / Trial / NCT07432490
A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome
Phase 2
Recruiting
16 enrolled
Oregon Health and Science University
Glut1 Deficiency Foundation · collab
RandomizedCrossoverTriple-blindTreatment
Summary
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of L-fucose supplementation in subjects with GLUT1 deficiency syndrome (GLUT1DS).
Timeline
- Start
- 2026-05-05
- Primary completion
- 2027-07
- Completion
- 2027-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | L-fucose | Unknown | 500 mg/kg | Oral |